openPR Logo
Press release

Controlled Release Delivery 2017: Strengthening innovation and overcoming the challenging regulatory landscape

02-02-2017 01:23 PM CET | Health & Medicine

Press release from: SMi Group

Controlled Release Delivery 2017

Controlled Release Delivery 2017

SMi will once again return to London for the 14th annual Controlled Release Delivery show which will take place on the 3rd & 4th of April.

Controlled Release Delivery 2017 will provide practical and critical discussions on the latest innovation in controlled release drug delivery. Alongside this, the conference will strengthen understanding in the latest regulatory landscape.

Aimed at drug development experts and formulation specialists, the 2017 event will explore key topics such as innovations in drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.

Key presentation not to miss:

Pranav Gupta, Principal Scientist from Merck & Co will be just one of the speakers presenting at this year’s show. Pranav will be presenting on 'Formulation Design & Considerations for Optimal Drug Product Performance of Oral Controlled Release Systems' where he will discuss the following:

• Drivers for CR development & oral CR landscape over the past ten years
• Key considerations for CR technology selection, pre-clinical considerations for CR assessment
• Share case studies across different oral CR delivery systems highlighting critical formulation considerations to ensure optimal DP performance
• Discuss emerging technologies for oral CR development

Also speaking at the conference includes controlled release experts from: Novartis Institutes for BioMedical Research, Janssen, GSK, Boehringer Ingelheim, Actelion, Merrion Pharmaceuticals and more...

Some 2017 Highlights include:
• Novartis optimise the success of biopharmaceutical approaches for controlled release delivery
• Can lipid suspensions improve oral bioavailability? Answers from Janssen
• Insights into the opportunities and limitations to improving solubility and bioavailability with Actelion
• Hear InnoCore Pharmaceuticals discuss microparticles and hydrogels for parenteral drug delivery
• Explore formulation design and optimal drug product performance of oral controlled release systems with Merck

A full speaker line-up and detailed conference agenda is available to download online at www.controlledreleasedelivery.com/openpr. For those looking to attend, there is currently a £100 discount available which expires on 28th February 2017.

Controlled Release Delivery
Strengthening innovation and overcoming the challenging regulatory landscape
3rd & 4th April 2017
London, UK
www.controlledreleasedelivery.com/openpr

Contact Information:
For all media enquiries contact Zoe Gale on Tel: +44 (0)20 7827 6032 / Email: zgale@smi-online.co.uk

To register for the conference, visit www.controlledreleasedelivery.com/openpr or contact Ameenah Begum for group bookings on Tel: +44 (0)20 7827 6166 / Email: abegum@smi-online.co.uk

To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk

---END---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Ground & First Floor
1 Westminister Bridge Road
London, SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Controlled Release Delivery 2017: Strengthening innovation and overcoming the challenging regulatory landscape here

News-ID: 426884 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Controlled

Automotive Silicon-Controlled Rectifier Market
Automotive Silicon-Controlled Rectifier Market Overview Featuring immunity to surges and transients in static states and commutations, our silicon-controlled rectifiers (SCR), also known as thyristors, are ideal for single- and three-phase power line networks, even in harsh environments up to 150°C. In addition to AC, DC and capacitive ignitor circuits, these unidirectional switches are found in high-voltage industrial circuits as well as automotive equipment and all other segments where electromechanical relays are
Passive Temperature Controlled Packaging Market 2023-2032: Temperature-Controlle …
In a world where the pharmaceutical industry is experiencing unprecedented growth due to an expanding global population, particularly the elderly, and a rising number of communicable and non-communicable diseases, the demand for both prescription and non-prescription drugs has never been higher. This surge in critical pharmaceutical needs has become a driving force behind the remarkable growth of the global passive temperature-controlled packaging market. Allied Market Research has recently unveiled a
Controlled Atmosphere Storage Using a DataTaker
DT80 Provides Single Solution & Saves Money A company contacted CAS DataLoggers with a controlled atmosphere storage environment project as part of pilot testing for a new process. To reduce costs, existing equipment was used wherever possible. The hostile atmosphere produced was found to be incompatible with available humidity sensor technologies, requiring these measurements to be derived in real time using measurements from secondary sensors. The price of logging different sensors
Temperature Controlled Packaging Systems Market
This report presents the worldwide Temperature Controlled Packaging Systems market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis. Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-temperature-controlled-packaging-systems-2025-971 The Temperature Controlled
Achieving Controlled Nucleation During Aseptic Lyophilization
Controlled nucleation is essential for obtaining high-quality lyophilized products with intra- and inter-batch consistency. Two approaches to achieving controlled nucleation have been investigated recently: creating a pressure differential and using an ice fog to insert seed crystals into the vials within the lyophilization chamber. Morrisa Jones, Senior Scientist, Vaccine Drug Product Development Merck, who is speaking at the SMi’s Groups’ Lyophilization USA Conference she will be comparing and contrasting two
Controlled Drug Delivery Market Controlled Drug Delivery Clinical Pipeline Repor …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1 Drug Delivery: An Advancing Trajectory 1.1 Preface Towards Drug Delivery 1.2 Idealism of Drug Delivery System 2. Introduction to Controlled Drug Delivery 2.1 Novel Drug Delivery Systems 2.2 Preamble to Controlled Drug Delivery 3. Evolution of Controlled Drug Delivery 3.1 First Generation 3.2 Second Generation 4. Fundamentals of Controlled Drug Delivery 4.1 Prerequisites